November 2020 FDA Recall Sodium Chloride by Hikma Pharmaceuticals Usa Inc.
D-0101-2021 - Failed pH Specifications

This Class II drug recall was voluntarily initiated by Hikma Pharmaceuticals Usa Inc. on November 3, 2020 for the product Sodium Chloride. The FDA reported the reason for recall as failed ph specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0101-2021

Reason for Recall
Failed pH Specifications: Out of Specification pH Test Results were found in Sodium Chloride Injection USP 0.9% 2 mL vial.
Initiated
11-03-2020
Reported
11-25-2020
Quantity
2,100,646 Vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Hikma Pharmaceuticals USA Inc.
Nationwide in the U.S.
Sodium Chloride Injection, USP, 0.9%, 0.308 mOsmol/mL, 2mL Single Dose Vial, Preservative Free, For use as a sterile diluent, Rx Only, Mfd. by. West-ward Eatontown, NJ 07724 USA, a) Vial NDC 0641-0497-17, b) Carton of 25 vials NDC 0641-0497-25.

Batch or Lot Expiration Information

Lot# a) Vial
Lot# s: 078338 Exp. 7/2021; Lot 088391, Exp. 08/2021; 098340, Exp. 09/2021; 108325 Exp. 10/2021; 010018 Exp. 1/2023; b) Carton
Lot# : 068322, Exp. 06/2021.